Plus   Neg

PerkinElmer Says US Investigation Does N't Target Company Or Its Personnel

Responding to Reuters' article, PerkinElmer Inc. (PKI) said Monday that it is not aware of wrongdoing by the company, as implied by Reuters, nor does PerkinElmer have any information that the company or any of the company's personnel are the target of a government investigation.

Earlier today, Reuters reported that PerkinElmer faces U.S. investigation into its role in an alleged Medicare fraud involving tens of thousands of unnecessary genetic cancer tests, earning millions of dollars.

Meanwhile, PerkinElmer said it has supported government efforts to identify and prevent abusive practices in healthcare.

Medical diagnostic firm said it has received subpoenas from the government regarding investigations into third parties, and has fully cooperated with authorities and will continue to do so.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration (FDA) has gone ahead with the approval of antiviral drug remdesivir as first treatment for COVID-19, notwithstanding last week's findings by the World Health Organization (WHO) that the drug is not effective for COVID-19 treatment. Thursday, Gilead Sciences announced that the FDA approved remdesivir, sold under the brand name Veklury. Integrated payments firm American Express Co. (AXP) reported Friday that net income for the third quarter declined to $1.1 billion or $1.30 per share from $1.8 billion or $2.08 per share in the prior-year quarter. Consolidated total revenues, net of interest expense, also decreased 20 percent to $8.8... The Federal Trade Commission or FTC has launched a new fraud reporting platform, using which, consumers can easily report fraud and all other consumer issues directly to the regulator. In a statement, the FTC said its new website, ReportFraud.ftc.gov, will provide a streamlined and user-friendly way to submit reports about scams, frauds, and bad business practices.
Follow RTT